| |
| |
|
| Insider
Information: |
Dawkins Keith D |
| Relationship: |
EVP, Global Chief Med.... |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
68,165 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,277,334 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
68,165 |
|
|
| Total
Value |
$5,277,334 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP, Global Chief Med.... |
2017-02-28 |
68,165 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2017-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,293 |
80,086 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2013-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,758 |
81,364 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2013-02-28 |
4 |
D |
$7.39 |
$11,780 |
D/D |
(1,594) |
81,802 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2013-11-21 |
4 |
S |
$12.00 |
$1,666,339 |
D/D |
(138,850) |
81,802 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,888 |
83,396 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2014-02-16 |
4 |
D |
$13.30 |
$16,199 |
D/D |
(1,218) |
83,957 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,373 |
85,175 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2017-02-28 |
4 |
D |
$24.55 |
$293,495 |
D/D |
(11,955) |
98,165 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
22,934 |
105,384 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,736 |
110,120 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2014-02-24 |
4 |
D |
$13.08 |
$165,240 |
D/D |
(12,633) |
110,173 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2014-02-27 |
4 |
D |
$13.30 |
$37,985 |
D/D |
(2,856) |
116,075 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,758 |
118,931 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2014-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
36,441 |
120,398 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2014-02-28 |
4 |
D |
$13.10 |
$41,108 |
D/D |
(3,138) |
122,562 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2014-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,408 |
122,806 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,625 |
125,700 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2015-01-01 |
4 |
D |
$13.25 |
$138,118 |
D/D |
(10,424) |
143,188 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2015-02-16 |
4 |
D |
$14.98 |
$16,433 |
D/D |
(1,097) |
145,466 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2015-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,375 |
146,563 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2016-05-10 |
4 |
S |
$22.15 |
$1,772,224 |
D/D |
(80,000) |
150,227 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,050 |
153,612 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2017-01-01 |
4 |
D |
$21.63 |
$113,622 |
D/D |
(5,253) |
156,647 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2017-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,673 |
161,900 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP, Global Chief Med. Off. |
• • – |
2015-02-23 |
4 |
D |
$16.31 |
$217,820 |
D/D |
(13,355) |
169,849 |
0 |
- |
|
70 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
